DarioHealth
DRIO
DarioHealth (DRIO) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.85
- EPS estimate
- −$1.22
- EPS surprise
- +30.04%
- Revenue surprise
- −12.56%
- Revenue
- $5.2M
- Revenue estimate
- $5.9M
- Reported
- Aug 11, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 11, 2026 | −$1.22 | −$0.85 | +30.04% | $5.2M | SEC |
| Q1 2026 | May 13, 2026 | −$1.48 | −$1.25 | +15.54% | $5.6M | SEC |
| Q4 2025 | Mar 19, 2026 | −$3.24 | −$2.27 | +30.07% | $5.2M | SEC |
| Q3 2025 | Nov 13, 2025 | −$4.90 | −$2.96 | +39.59% | $5.0M | SEC |
| Q2 2025 | Aug 12, 2025 | −$4.67 | −$3.60 | +22.86% | $5.4M | SEC |
| Q1 2025 | May 14, 2025 | −$2.00 | −$2.80 | −40.00% | $6.8M | SEC |
| Q4 2024 | Mar 10, 2025 | −$6.67 | −$1.60 | +76.00% | $7.6M | SEC |
| Q3 2024 | Nov 7, 2024 | −$4.33 | −$5.00 | −15.39% | $7.4M | SEC |
| Q2 2024 | Aug 8, 2024 | −$8.90 | −$1.60 | +82.02% | $6.3M | SEC |
| Q1 2024 | May 15, 2024 | −$5.90 | −$4.00 | +32.20% | $5.8M | SEC |
| Q4 2023 | Mar 28, 2024 | −$7.80 | −$8.20 | −5.13% | $3.6M | SEC |
| Q3 2023 | Nov 2, 2023 | −$10.40 | −$9.80 | +5.77% | $3.5M | SEC |
| Q2 2023 | Aug 10, 2023 | −$10.28 | −$11.60 | −12.84% | $6.2M | SEC |
| Q1 2023 | May 11, 2023 | −$9.96 | −$9.00 | +9.64% | $7.1M | SEC |
| Q4 2022 | Mar 9, 2023 | −$12.20 | −$8.40 | +31.15% | $6.8M | SEC |
| Q3 2022 | Nov 14, 2022 | −$15.26 | −$12.80 | +16.10% | $6.6M | — |
| Q2 2022 | Aug 15, 2022 | −$15.09 | −$14.80 | +1.89% | $6.2M | — |
| Q1 2022 | May 12, 2022 | −$19.14 | −$14.80 | +22.69% | $8.1M | — |
| Q4 2021 | Mar 22, 2022 | −$23.14 | −$23.80 | −2.84% | $6.0M | — |
| Q3 2021 | Nov 15, 2021 | −$19.74 | −$27.19 | −37.72% | $5.6M | — |
Quarterly revenue
Frequently asked questions
When did DarioHealth (DRIO) last report earnings?
DarioHealth last reported on Aug 11, 2026, covering fiscal Q2 2026.
Did DRIO beat earnings estimates?
Yes. DarioHealth reported EPS of −$0.85 for Q2 2026 against a −$1.22 estimate — a 30.04% beat.
How much revenue did DRIO report last quarter?
DarioHealth reported $5.2M in revenue for Q2 2026, against a consensus estimate of $5.9M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.